Journal Article10.3390/pr11072096
Data-Driven Modeling Methods and Techniques for Pharmaceutical Processes
11
TL;DR: In this article , a review of data-driven methods applied in pharmaceutical processes, based on the mathematical and algorithmic principles behind the modeling methods, is presented, and two case studies, including dynamic reaction data modeling and catalyst-kinetics prediction of cross-coupling reactions, are presented to illustrate the power and advantages of different data driven models.
read more
Abstract: As one of the most influential industries in public health and the global economy, the pharmaceutical industry is facing multiple challenges in drug research, development and manufacturing. With recent developments in artificial intelligence and machine learning, data-driven modeling methods and techniques have enabled fast and accurate modeling for drug molecular design, retrosynthetic analysis, chemical reaction outcome prediction, manufacturing process optimization, and many other aspects in the pharmaceutical industry. This article provides a review of data-driven methods applied in pharmaceutical processes, based on the mathematical and algorithmic principles behind the modeling methods. Different statistical tools, such as multivariate tools, Bayesian inferences, and machine learning approaches, i.e., unsupervised learning, supervised learning (including deep learning) and reinforcement learning, are presented. Various applications in the pharmaceutical processes, as well as the connections from statistics and machine learning methods, are discussed in the narrative procedures of introducing different types of data-driven models. Afterwards, two case studies, including dynamic reaction data modeling and catalyst-kinetics prediction of cross-coupling reactions, are presented to illustrate the power and advantages of different data-driven models. We also discussed current challenges and future perspectives of data-driven modeling methods, emphasizing the integration of data-driven and mechanistic models, as well as multi-scale modeling.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Artificial Intelligence's Impact on Drug Discovery and Development From Bench to Bedside
K. S. Vidhya,Ayesha Sultana,Naveen Kumar M,Harish Rangareddy +3 more
TL;DR: This research presents an AI-based approach that can predict drug release profiles, incorporate patient-specific factors, and optimize dosage regimens to achieve tailored and effective therapies in the field of pharmaceutical sciences.
27
Optimizing Healthcare Throughput: The Role of Machine Learning and Data Analytics
Priyanka S. Deorankar,Vivek Vaidya,Neha Munot,Kishor S. Jain,Abhinandan Patil +4 more
- 01 Jan 2024
4
Recent trends and perspectives of artificial intelligence-based machine learning from discovery to manufacturing in biopharmaceutical industry
Ravi Maharjan,Jae Chul Lee,Kyeong Lee,H. Han,Ki Hyun Kim,Seong Hoon Jeong +5 more
TL;DR: This study summarizes the application of ML tools in drug discovery, formulation development, and optimization, in addition to continuous manufacturing and characterization of advanced drug delivery systems such as biopharmaceutical formulations including mRNA-LNP vaccines, microfluidics, and microparticle dosage forms.
3
Data-Driven Enterprise Architecture for Pharmaceutical R&D
TL;DR: Data-driven enterprise architecture for pharmaceutical R&D focuses on the holistic transformation of pharmaceutical organizations through data-driven insights, leveraging the Resource-Based View (RBV) theory and dynamic capabilities concept. The DDA framework emphasizes domain decomposition, distributed ownership, and federated governance to enable data harmonization across the organization.
2
Machine Learning Predicts Drug Release Profiles and Kinetic Parameters Based on Tablets’ Formulations
Chrystalla Protopapa,Angeliki Siamidi,Amelia Adibe Eneli,Moe Elbadawi,Marilena Vlachou +4 more
TL;DR: This study explores the use of machine learning to predict drug release profiles and kinetic parameters from tablets' formulations, achieving R2 values of 0.635-0.601 using random forest and XGB models, and demonstrating potential for accelerating pharmaceutical development.
1
References
Random Forests
Leo Breiman
- 01 Oct 2001
TL;DR: Internal estimates monitor error, strength, and correlation and these are used to show the response to increasing the number of features used in the forest, and are also applicable to regression.
A fast learning algorithm for deep belief nets
TL;DR: A fast, greedy algorithm is derived that can learn deep, directed belief networks one layer at a time, provided the top two layers form an undirected associative memory.
A tutorial on support vector regression
TL;DR: This tutorial gives an overview of the basic ideas underlying Support Vector (SV) machines for function estimation, and includes a summary of currently used algorithms for training SV machines, covering both the quadratic programming part and advanced methods for dealing with large datasets.
A comparison of three methods for selecting values of input variables in the analysis of output from a computer code
TL;DR: In this paper, two sampling plans are examined as alternatives to simple random sampling in Monte Carlo studies and they are shown to be improvements over simple sampling with respect to variance for a class of estimators which includes the sample mean and the empirical distribution function.
10.3K
Markov Chain Monte Carlo in Practice
TL;DR: The Markov Chain Monte Carlo Implementation Results Summary and Discussion MEDICAL MONITORING Introduction Modelling Medical Monitoring Computing Posterior Distributions Forecasting Model Criticism Illustrative Application Discussion MCMC for NONLINEAR HIERARCHICAL MODELS.